These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7240201

  • 1. A protein activator for the enzymic hydrolysis of GM2 ganglioside.
    Li SC, Hirabayashi Y, Li YT.
    J Biol Chem; 1981 Jun 25; 256(12):6234-40. PubMed ID: 7240201
    [No Abstract] [Full Text] [Related]

  • 2. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
    Hechtman P, Kachra Z.
    Biochem J; 1980 Mar 01; 185(3):583-91. PubMed ID: 7387624
    [Abstract] [Full Text] [Related]

  • 3. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
    Inui K, Wenger DA.
    Biochem Biophys Res Commun; 1982 Mar 30; 105(2):745-51. PubMed ID: 6807306
    [No Abstract] [Full Text] [Related]

  • 4. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
    Hirabayashi Y, Li YT, Li SC.
    Seikagaku; 1983 Mar 30; 55(1):1-13. PubMed ID: 6405000
    [No Abstract] [Full Text] [Related]

  • 5. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
    Wynn CH.
    Biochem J; 1986 Dec 15; 240(3):921-4. PubMed ID: 3827882
    [Abstract] [Full Text] [Related]

  • 6. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide.
    Li SC, Kihara H, Serizawa S, Li YT, Fluharty AL, Mayes JS, Shapiro LJ.
    J Biol Chem; 1985 Feb 10; 260(3):1867-71. PubMed ID: 2981875
    [Abstract] [Full Text] [Related]

  • 7. Interaction of GM2 activator protein with glycosphingolipids.
    Hama Y, Li YT, Li SC.
    J Biol Chem; 1997 Jan 31; 272(5):2828-33. PubMed ID: 9006924
    [Abstract] [Full Text] [Related]

  • 8. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G, Linke T, Uhlhorn-Dierks G, Sandhoff K.
    J Biol Chem; 2000 Nov 17; 275(46):35814-9. PubMed ID: 10942779
    [Abstract] [Full Text] [Related]

  • 9. Expression and specificity of human GM2 activator protein.
    Wu YY, Lockyer JM, Sugiyama E, Pavlova NV, Li YT, Li SC.
    J Biol Chem; 1994 Jun 10; 269(23):16276-83. PubMed ID: 8206933
    [Abstract] [Full Text] [Related]

  • 10. Activator proteins for the catabolism of glycosphingolipids.
    Li YT, Li SC.
    Adv Exp Med Biol; 1984 Jun 10; 174():213-26. PubMed ID: 6234759
    [No Abstract] [Full Text] [Related]

  • 11. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P, Isaacs C, Smith-Jones L.
    Can J Biochem Cell Biol; 1985 Aug 10; 63(8):830-8. PubMed ID: 2933135
    [Abstract] [Full Text] [Related]

  • 12. Sphingolipid hydrolases and activator proteins.
    Bierfreund U, Kolter T, Sandhoff K.
    Methods Enzymol; 2000 Aug 10; 311():255-76. PubMed ID: 10563332
    [No Abstract] [Full Text] [Related]

  • 13. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A, Conzelmann E, Sandhoff K.
    Clin Chim Acta; 1980 Dec 22; 108(3):361-8. PubMed ID: 6781795
    [Abstract] [Full Text] [Related]

  • 14. Activator proteins for lysosomal glycolipid hydrolysis.
    Conzelmann E, Sandhoff K.
    Methods Enzymol; 1987 Dec 22; 138():792-815. PubMed ID: 2885714
    [No Abstract] [Full Text] [Related]

  • 15. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
    Vogel A, Fürst W, Abo-Hashish MA, Lee-Vaupel M, Conzelmann E, Sandhoff K.
    Arch Biochem Biophys; 1987 Dec 22; 259(2):627-38. PubMed ID: 3426245
    [Abstract] [Full Text] [Related]

  • 16. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
    Burg J, Banerjee A, Conzelmann E, Sandhoff K.
    Hoppe Seylers Z Physiol Chem; 1983 Jul 22; 364(7):821-9. PubMed ID: 6225718
    [Abstract] [Full Text] [Related]

  • 17. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F, Remmel N, Breiden B, Klingenstein R, Schwarzmann G, Sandhoff K.
    Biochimie; 2003 Jul 22; 85(3-4):439-48. PubMed ID: 12770782
    [Abstract] [Full Text] [Related]

  • 18. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
    Conzelmann E, Burg J, Stephan G, Sandhoff K.
    Eur J Biochem; 1982 Apr 01; 123(2):455-64. PubMed ID: 6210531
    [Abstract] [Full Text] [Related]

  • 19. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
    Li SC, Wu YY, Sugiyama E, Taki T, Kasama T, Casellato R, Sonnino S, Li YT.
    J Biol Chem; 1995 Oct 13; 270(41):24246-51. PubMed ID: 7592631
    [Abstract] [Full Text] [Related]

  • 20. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P, Gordon BA, Ng Ying Kin NM.
    Pediatr Res; 1982 Mar 13; 16(3):217-22. PubMed ID: 6801612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.